Biogen (BIIB) Gross Profit (2009 - 2026)

Biogen has reported Gross Profit for 18 years, with the latest figure at $2.0 billion in Q2 2026.

• On a quarterly basis, Gross Profit fell 3.99% year-over-year to $2.0 billion in Q2 2026; TTM through Jun 2026 was $7.4 billion, a 1.6% decrease from a year earlier, with the FY2025 full-year figure at $7.5 billion, up 1.64% from the prior year.
• Gross Profit was $2.0 billion for Q2 2026 at Biogen, up from $1.8 billion in the prior quarter.
• The five-year high for Gross Profit was $2.4 billion in Q4 2022, with the low at $1.7 billion in Q1 2024.
• Average Gross Profit over 5 years is $1.9 billion, with a median of $1.9 billion recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Gross Profit fell 19.77% in 2022, then increased 6.34% in 2025.
• Over 5 years, Gross Profit stood at $2.4 billion in 2022, then fell by 6.63% to $2.2 billion in 2023, then fell by 15.8% to $1.9 billion in 2024, then declined by 4.67% to $1.8 billion in 2025, then grew by 9.82% to $2.0 billion in 2026.
• The last three Gross Profit figures came in at $2.0 billion (Q2 2026), $1.8 billion (Q1 2026), and $1.8 billion (Q4 2025), per Business Quant data.